The European Commission has dropped nearly all of its order of 60 million doses of a new COVID-19 vaccine from French firm Valneva, the EU executive said on Wednesday, in a move that all but wipes out the shot's value for the company. The EU agreed in November last year to buy the vaccine, with the first 27 million doses to be delivered this year, but the vaccine received approval only last month after protracted delays.
European countries are now well supplied with other vaccines, and vaccination programmes have slowed.
